加利福尼亚州27M奖,用于建立3个中心,扩大服务不足的社区获得基因治疗的机会。 California awards $27M to build 3 centers expanding access to gene therapy for underserved communities.

加利福尼亚再生医学研究所已拨款2700万美元,在南洛杉矶,内陆帝国和沙漠地区以及中央谷区建立三个社区护理卓越中心,为服务不足的人群扩大获得细胞和基因疗法临床试验的机会. The California Institute for Regenerative Medicine has awarded $27 million to establish three Community Care Centers of Excellence in South Los Angeles, the Inland Empire and Desert Region, and the Central Valley to expand access to cell and gene therapy clinical trials for underserved populations. 这些中心定于2026年初启动,将通过建立当地治疗基础设施、提供病人支助服务和创造劳动力培训机会,解决地理、经济和社会障碍。 The centers, set to launch in early 2026, will address geographic, economic, and social barriers by building local treatment infrastructure, offering patient support services, and creating workforce training opportunities. 该倡议在社区投入的推动下,旨在缩小健康差距,将侧重于镰状细胞疾病、癌症、帕金森氏病和稀有遗传疾病等状况,并致力于公平获得全加利福尼亚再生医学进步。 The initiative, driven by community input and aimed at reducing health disparities, will focus on conditions like sickle cell disease, cancer, Parkinson’s, and rare genetic disorders, with a commitment to equitable access to regenerative medicine advancements across California.